Research programme: DNA-based monoclonal antibodies - GeneOne Life Science
Alternative Names: Anti-Aβ antibody; Anti-Her2 antibody; Anti-PD1 antibodyLatest Information Update: 04 Sep 2023
At a glance
- Originator GeneOne Life Science
- Developer Asan Medical Center; GeneOne Life Science; Kangwon National University; Yonsei University Health System
- Class Antibodies; DNA
- Mechanism of Action Amyloid beta-protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
- Discontinued Alzheimer's disease
Most Recent Events
- 04 Sep 2023 Discontinued - Preclinical for Alzheimer's disease in South Korea (Parenteral) (GeneOne Life Science pipeline, September 2023)
- 28 Mar 2020 No recent reports of development identified for preclinical development in Alzheimer's-disease in South Korea (Parenteral, Injection)
- 28 Mar 2020 No recent reports of development identified for preclinical development in Cancer in South Korea (Parenteral, Injection)